Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson’s Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer

Many potential disease modifying therapies have been identified as suitable for clinical evaluation in Parkinson’s disease (PD). Currently, the evaluation of compounds in phase II and phase III clinical trials in PD are set up in isolation, a process that is lengthy, costly and lacks efficiency. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeissler, Marie-Louise, Li, Vivien, Parmar, Mahesh K.B., Carroll, Camille Buchholz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242843/
https://www.ncbi.nlm.nih.gov/pubmed/32116263
http://dx.doi.org/10.3233/JPD-191856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242843/
https://www.ncbi.nlm.nih.gov/pubmed/32116263
http://dx.doi.org/10.3233/JPD-191856

Ejemplares similares